RIGEL PHARMACEUTICALS INC (RIGL)

US7665596034 - Common Stock

1.1  -0.02 (-2.22%)

After market: 1.09 -0.01 (-0.91%)

Full estimates are only available for subscribed users, you can see which data is available below.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026 2027 2028 2029 2030
Revenue
YoY % growth
149.2M
37.38%		120.2M
-19.44%		116.882M
-2.76%		151.97M
30.02%
EBITDA
YoY % growth
-7.84M
72.29%		-53.3M
-579.85%		-19.253M
63.88%		-14.445M
24.97%		N/AN/AN/AN/A
EBIT
YoY % growth
-9M
68.97%		-54.3M
-503.33%		-20.491M
62.26%		-8.256M
59.71%
Operating Margin
-6.03%-45.17%-17.53%-5.43%
EPS
YoY % growth
-0.11
31.25%		-0.34
-209.09%		-0.15
55.88%		-0.07
56.36%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q1 / 24 Q2 / 24 Q3 / 24 Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25
EPS
Q2Q % growth		-0.03
63.24%
Revenue
Q2Q % growth		31.91M
22.40%
EBITDA
Q2Q % growth		-3.938MN/AN/AN/AN/A
EBIT
Q2Q % growth		-4.668M
63.33%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2023
Q2Q % growth		 0.00
-100.00%		-0.030.03100.00%
Q3 2023
Q2Q % growth		 -0.03
72.73%		-0.070.0458.57%
Q2 2023
Q2Q % growth		 -0.04
50.00%		-0.080.0449.72%
Q1 2023
Q2Q % growth		 -0.08
50.00%		-0.100.0219.56%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2023
Q2Q % growth		 35.792M
-30.20%		34.784M1.008M2.90%
Q3 2023
Q2Q % growth		 28.13M
25.52%		27.745M385K1.39%
Q2 2023
Q2Q % growth		 26.89M
-9.83%		26.218M672K2.56%
Q1 2023
Q2Q % growth		 26.07M
55.73%		24.554M1.516M6.17%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS-0.8% 28.81% 31.24% 15.57%
Revenue-0.34% -4.14% 6.2% 8.69%